Skip to content
Screener

QXO, Inc. QXO Business Segments — Stock-Based Comp

Similar metrics at other companies

Credo Technology Group Holding Ltd logo
CRDOReportable Segment — Stock-Based Comp
$50.76M+84.6%
Summit Therapeutics logo
SMMTReportable Segment — Stock-Based Comp
$72.79M+556%
Progress Software logo
PRGSReportable Segment — Stock-Based Comp
$20.51M+22.5%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Stock-Based Comp
$28.38M+43.3%
Lifecore Biomedical, Inc. logo
LFCRReportable Segment — Stock-Based Comp
$2.09M
Lumen Technologies logo
LUMNReportable Segment — Stock-Based Comp
$13M+30.0%

Other financials

Income statement

See full
Revenue$1.7B+12,716%
Gross profit$409.3M+7,480%
Operating income-$251.9M-541%
Net income-$227.1M-2,681%
EPS (diluted)-$0.35-1,067%

Balance sheet

See full
Cash & equivalents$3.1B-40.0%
Total debt$4.0B+98,757%
Total equity$10.2B+101%
Total assets$16.7B+226%

Cash flow

See full
Operating cash flow$70.6M+93.4%
CapEx$22.5M+15,311%
Free cash flow$48.1M+32.3%

Valuation

See full
Market cap$17.16B+33.7%
Enterprise value$18.06B+24.4%
P/S-4.6×

Profitability

See full
Gross margin23.1%-17.7pp
Operating margin-5.3%-2.6pp
Net margin-6%-71.7pp
FCF margin2.3%-214pp

Returns & leverage

See full
Return on equity-6.8%-8.2pp
Debt / equity0.4×+0.4×
Current ratio3.3×-91.9×

Where this comes from

Reported directly by QXO, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: QXO, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:18 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-034130
(in millions)Three Months Ended March 31, 20262025
Total net sales$1,730.2$13.5
Less:
Cost of products sold$1,320.9$8.1
Selling, general administrative expenses(1)457.824.2
Stock-based compensation39.220.2
Other segment items139.4(47.8)
Net (loss) income$(227.1)$8.8
(1) Excludes stock-based compensation.

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is QXO, Inc.'s business segments — stock-based comp?
QXO, Inc. (QXO) reported business segments — stock-based comp of $39.2M in Q1 2026.
How has QXO, Inc.'s business segments — stock-based comp changed year-over-year?
QXO, Inc.'s business segments — stock-based comp increased by 94.1% year-over-year, from $20.2M to $39.2M.
What is the long-term trend for QXO, Inc.'s business segments — stock-based comp?
Over 2 years (2023 to 2025), QXO, Inc.'s business segments — stock-based comp has grown at a 5836.7% compound annual growth rate (CAGR), from $41K to $144.5M.
What does business segments — stock-based comp mean?
This reflects the non-cash expense recognized by the segment for equity-based awards granted to employees and management. It is a critical component of total compensation and reflects the cost of aligning employee incentives with shareholder interests. Investors monitor this to assess the true economic cost of labor and potential dilution.

Ask your AI about QXO, Inc.'s business segments — stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude